Automated screening tool for diabetic retinopathy
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a new automated tool that checks for diabetic retinopathy, a common eye problem in people with diabetes. It may help catch the condition early, so vision loss can be prevented.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 22 years old or older.
- You need a diagnosis of diabetes or diabetic retinopathy.
- You must be able to understand the study and sign a consent form.
- You cannot have had laser treatment or injections in your eyes.
- You cannot have had eye surgery other than simple cataract surgery.
- You must be willing to have your eyes dilated for imaging.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI program called DRISTi to screen for diabetic eye disease by taking pictures of the back of your eye. It's designed for adults with diabetes who haven't had major eye treatments or vision loss.
This trial tests an AI system that automatically checks eye photos for signs of diabetic retinopathy, a diabetes complication that can harm vision. If you have diabetes, this study may help detect the condition earlier and prevent vision loss.
This study looks at how images and other tests of the eye can help predict diabetic retinopathy, an eye problem caused by diabetes that can lead to vision loss. If you have diabetes, your eye health will be monitored closely. If you do not, you may participate as a healthy comparison.
This study uses an artificial intelligence (AI) tool to analyze eye images in people with type 2 diabetes. The goal is to see if the AI can help detect early signs of diabetic eye disease, so you can get the right care sooner.
This study tests whether a computer program (artificial intelligence) can use your eye scan images to help diagnose certain eye conditions. It might help catch problems earlier or more accurately, which could lead to better treatment.
This trial tests if an AI tool can help detect diabetic retinopathy and age-related macular degeneration in older adults visiting family medicine or geriatric clinics. It aims to catch these eye conditions early, before they cause vision loss.
Hear when a new Diabetic Retinopathy (DR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.